Scholarlink

<p>Pancreatic cancer remains a highly lethal malignancy with limited treatment options. Given the versatile bioactivity of quinazoline derivatives, which are regarded as a promising scaffold for anticancer drug discovery, we designed and synthesized a series of novel quinazoline analogues. Their cytotoxicity was evaluated in three pancreatic cancer cell lines (HPAC, AsPC-1, and MIA PaCa-2), leading to the identification of compound <b>5a</b>, which exhibited potent effects across all tested cell lines. Further investigation of anticancer activity indicated that <b>5a</b> significantly inhibited DNA synthesis, clonogenesis, and migration in MIA PaCa-2 cells. Mechanism study revealed that <b>5a</b> disrupted autophagy, as evidenced by downregulation of Beclin-1 expression and accumulation of LC3B-II and p62, through a mechanism independent of the canonical AMPK-mTOR-ULK1 signaling pathway. This study provides a promising active scaffold for the development of anti-pancreatic cancer agents.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Discovery of quinazoline-based derivatives as novel autophagy inhibitors in pancreatic cancer

  • 期刊论文

  • 发表日期：

    2026年2月19日

查看全文
  • Dongxuan Ni,
  • Man Jin,
  • Hongyuan Zhou,
  • Ruoxi Xue,
  • Fudong Wu,
  • Tongyi Pu,
  • Bin Liang,
  • Ruihan Zhang,
  • Jia Su,
  • Weilie Xiao

摘要

Pancreatic cancer remains a highly lethal malignancy with limited treatment options. Given the versatile bioactivity of quinazoline derivatives, which are regarded as a promising scaffold for anticancer drug discovery, we designed and synthesized a series of novel quinazoline analogues. Their cytotoxicity was evaluated in three pancreatic cancer cell lines (HPAC, AsPC-1, and MIA PaCa-2), leading to the identification of compound 5a, which exhibited potent effects across all tested cell lines. Further investigation of anticancer activity indicated that 5a significantly inhibited DNA synthesis, clonogenesis, and migration in MIA PaCa-2 cells. Mechanism study revealed that 5a disrupted autophagy, as evidenced by downregulation of Beclin-1 expression and accumulation of LC3B-II and p62, through a mechanism independent of the canonical AMPK-mTOR-ULK1 signaling pathway. This study provides a promising active scaffold for the development of anti-pancreatic cancer agents.